English | Español
Patient Daily | Mar 30, 2026

Biotech sector urged to adapt to new funding realities, says Ali Pashazadeh
Patient Daily | Mar 30, 2026

Novartis announces $480 million investment to expand operations in China
Patient Daily | Mar 30, 2026

Rezolute receives FDA support for hypoglycemia drug after failed Phase 3 trial
Patient Daily | Mar 30, 2026

Aardvark Therapeutics pauses two obesity trials after detecting cardiac concerns
Patient Daily | Mar 30, 2026

FDA releases draft guidance on alternatives to animal testing for drug development
Patient Daily | Mar 30, 2026

Study finds walking patterns may help distinguish Lewy body dementia from Parkinson’s disease
Patient Daily | Mar 30, 2026

Gilead announces $2.1 billion acquisition of Ouro Medicines and other industry updates
Patient Daily | Mar 30, 2026

UCB announces $2 billion biologics manufacturing facility in Georgia

Trending
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
A. R. Baird | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science